Literature DB >> 10584886

Tobacco and the risk of acute leukaemia in adults.

E V Kane1, E Roman, R Cartwright, J Parker, G Morgan.   

Abstract

Self-reported smoking histories were collected during face-to-face interviews with 807 patients with acute leukaemia and 1593 age- and sex-matched controls. Individuals who had smoked regularly at some time during their lives were more likely to develop acute leukaemia than those who had never smoked (odds ratio (OR) = 1.2, 95% confidence interval (CI) 1.0-1.4). The association was strongest for current smokers, defined here as smoking 2 years before diagnosis (OR = 1.4, 95% CI 1.1-1.7). With respect to the numbers of years smoked, risk estimates were raised in all groups except those who had smoked for fewer than 10 years. Similarly, the odds ratio decreased as the number of years 'stopped smoking' increased, falling to one amongst those who had given up smoking for more than 10 years. No significant linear trends were found, however, with either the numbers of years smoked or the numbers of years stopped smoking, and no significant differences were found between AML and ALL.

Entities:  

Mesh:

Year:  1999        PMID: 10584886      PMCID: PMC2374333          DOI: 10.1038/sj.bjc.6690833

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Cigarette smoking and leukemia.

Authors:  H Austin; P Cole
Journal:  J Chronic Dis       Date:  1986

2.  The leukocyte count: associations with intensity of smoking and persistence of effect after quitting.

Authors:  D B Petitti; H Kipp
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

3.  Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking.

Authors:  P Hersey; D Prendergast; A Edwards
Journal:  Med J Aust       Date:  1983-10-29       Impact factor: 7.738

4.  DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.

Authors:  F P Perera; R M Santella; D Brenner; M C Poirier; A A Munshi; H K Fischman; J Van Ryzin
Journal:  J Natl Cancer Inst       Date:  1987-09       Impact factor: 13.506

5.  Age and sex distributions of hematological malignancies in the U.K.

Authors:  R J McNally; D Rowland; E Roman; R A Cartwright
Journal:  Hematol Oncol       Date:  1997-11       Impact factor: 5.271

6.  Cigarette smoking and leukemia.

Authors:  R K Severson
Journal:  Cancer       Date:  1987-07-15       Impact factor: 6.860

7.  Intercensal trends in cigarette smoking in New Zealand 2: Social and occupational factors.

Authors:  D R Hay; F H Foster
Journal:  N Z Med J       Date:  1984-06-27

8.  Benzene and leukemia. An epidemiologic risk assessment.

Authors:  R A Rinsky; A B Smith; R Hornung; T G Filloon; R J Young; A H Okun; P J Landrigan
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

9.  The effect of tobacco smoking on the frequency of sister chromatid exchanges in human lymphocyte chromosomes.

Authors:  R Ghosh; P K Ghosh
Journal:  Cancer Genet Cytogenet       Date:  1987-07

10.  Benzene as a leukemogenic and carcinogenic agent.

Authors:  M Aksoy
Journal:  Am J Ind Med       Date:  1985       Impact factor: 2.214

View more
  15 in total

1.  Representativeness of samples from general practice lists in epidemiological studies: case-control study.

Authors:  A G Smith; N T Fear; G R Law; E Roman
Journal:  BMJ       Date:  2004-02-27

2.  Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

Authors:  J M Allan; C P Wild; S Rollinson; E V Willett; A V Moorman; G J Dovey; P L Roddam; E Roman; R A Cartwright; G J Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Malin Hultcrantz; Åsa R Derolf; Ola Landgren; Lynn R Goldin
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

4.  Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.

Authors:  L J Worrillow; A G Smith; K Scott; M Andersson; A J Ashcroft; G M Dores; B Glimelius; E Holowaty; G H Jackson; G L Jones; C F Lynch; G Morgan; E Pukkala; D Scott; H H Storm; P R Taylor; M Vyberg; E Willett; L B Travis; J M Allan
Journal:  J Med Genet       Date:  2007-10-24       Impact factor: 6.318

5.  Occupational exposure to electromagnetic fields and acute leukaemia: analysis of a case-control study.

Authors:  E V Willett; P A McKinney; N T Fear; R A Cartwright; E Roman
Journal:  Occup Environ Med       Date:  2003-08       Impact factor: 4.402

6.  MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.

Authors:  Nathan A Ellis; Dezheng Huo; Ozlem Yildiz; Lisa J Worrillow; Mekhala Banerjee; Michelle M Le Beau; Richard A Larson; James M Allan; Kenan Onel
Journal:  Blood       Date:  2008-04-21       Impact factor: 22.113

7.  Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation.

Authors:  Jessica R B Musselman; Cindy K Blair; James R Cerhan; Phuong Nguyen; Betsy Hirsch; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2013-05-02       Impact factor: 2.984

8.  Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.

Authors:  Ina Novak; Ozren Jaksić; Tomislav Kulis; Katarina Batinjan; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

9.  Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.

Authors:  A V Moorman; E Roman; R A Cartwright; G J Morgan
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review.

Authors:  Wei-Ping Chen; Wen-Fang Chiang; Hung-Ming Chen; Jenq-Shyong Chan; Po-Jen Hsiao
Journal:  Healthcare (Basel)       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.